Dravet Syndrome/Lennox-Gastaut Syndrome research hub

An Open-label, Non-randomized, Phase 3 Study to Evaluate the Efficacy and Safety of Soticlestat in Participants With Dravet Syndrome or Lennox-Gastaut Syndrome Who Have Been Exposed to Fenfluramine.

This study is testing a new medicine, Soticlestat, for people aged 18 and over with severe epilepsy called Dravet Syndrome or Lennox-Gastaut Syndrome. It's to see if it helps reduce seizures and if it's safe, especially for those who have previously taken another epilepsy medicine called Fenfluramine.